MRI-guided laser ablation of neuroendocrine tumor hepatic metastases.

Acta Radiol Short Rep 2014 Jan 23;3(1):2047981613499753. Epub 2014 Jan 23.

Department of Radiology, Oulu University Hospital, Oulu, Finland.

Background: Neuroendocrine tumors (NET) represent a therapeutically challenging and heterogeneous group of malignancies occurring throughout the body, but mainly in the gastrointestinal system.

Purpose: To describe magnetic resonance imaging (MRI)-guided laser ablation of NET liver metastases and assess its role within the current treatment options and methods.

Material And Methods: Two patients with NET tumor hepatic metastases were treated with MRI-guided interstitial laser ablation (LITT). Three tumors were treated. Clinical follow-up time was 10 years.

Results: Both patients were successfully treated. There were no local recurrences at the ablation site during the follow-up. Both patients had survived at 10-year follow-up. One patient is disease-free.

Conclusion: MRI-guided laser ablation can be used to treat NET tumor liver metastases but combination therapy and a rigorous follow-up schedule are recommended.

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047981613499753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001425PMC
January 2014
4 Reads

Publication Analysis

Top Keywords

laser ablation
16
mri-guided laser
12
net tumor
8
liver metastases
8
tumor hepatic
8
hepatic metastases
8
ablation
5
metastases assess
4
disease-freeconclusion mri-guided
4
patient disease-freeconclusion
4
assess role
4
role current
4
treated clinical
4
net liver
4
follow-up
4
magnetic resonance
4
imaging mri-guided
4
resonance imaging
4
recurrences ablation
4
follow-up patient
4

Similar Publications